Moderna CEO Bancel steps down
Moderna’s Bancel steps down as sales chief, keeps CEO role
Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter. He will remain chief executive of the biotech company. Moderna president Stephen Hoge will assume responsibility of sales as well ...
Last month, during a Senate hearing in which Moderna CEO Stéphane Bancel testified regarding the quadrupling in list price of the company’s Covid-19 vaccine, he cited lower consumer demand as ...
With COVID-19 revenues now shrinking fast, Moderna chief executive Stéphane Bancel has taken the decision to rein in spending and reduce the number of active development programmes, which have ...
CEO Stéphane Bancel highlighted the company’s success in respiratory vaccines and outlined a focus on five non-respiratory products aiming for approvals by 2027. However, the biotech company ...
Fewer injections would be more convenient and simpler, Moderna says. Chief executive Stephane Bancel told BBC News he hoped the messenger ribonucleic acid (mRNA) vaccine could be made widely ...
"Moderna now has five respiratory vaccines with positive Phase 3 results and expects to submit three for approval this year," said Moderna CEO Stéphane Bancel in a statement. "In addition ...
Stéphane Bancel told CNN Business that he predicts the world will see a once-a-year vaccine in the coming years that protects against strains of COVID-19, the flu, or any other prevalent viruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback